4-(Chloromethyl)tetrahydro-2H-pyran

Catalog No. :
ACXHZD317
CAS No. :
863324-23-6
Molecular Formula :
C6H11ClO
Molecular Weight :
134.61

IUPAC Name:4-(chloromethyl)tetrahydro-2H-pyran

4-(Chloromethyl)tetrahydro-2H-pyran structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$139.00Login to see priceIn stockInquiry
25g98%$674.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Chloromethyl)tetrahydro-2H-pyran
IUPAC Name4-(chloromethyl)tetrahydro-2H-pyran
MDL No.MFCD16745652
Molecular FormulaC6H11ClO
Molecular Weight134.61
SMILESClCC1CCOCC1
InChI KeyDULFMEBLCDFSDB-UHFFFAOYSA-N
SynonymJ-650209 | AB71513 | FT-0732633 | C77585 | AKOS011672954 | EN300-62685 | MFCD16745652 | SY184648 | 4-(chloromethyl)-tetrahydro-2H-pyran | 4-(CHLOROMETHYL)TETRAHYDRO-2H-PYRAN | ZB1192 | 4-(Chloromethyl)pyran | DULFMEBLCDFSDB-UHFFFAOYSA-N | SCHEMBL3579589 |
CAS No.863324-23-6
PubChem CID62386193

Safety Data

Pictogram
FlammableCorrosive
Signal Word
Gefahr
Hazard Statement(s)
H225-H314
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACXHZD317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSVLE763 route compound structure diagram
    ACSVLE76314774-37-9 In Stock
  4. Then
  5. ACXHZD317 route product structure diagram
    ACXHZD317863324-23-6 In Stock
Inquiry

2. ACXHZD317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXHZD317 route compound structure diagram
    ACXHZD317863324-23-6 In Stock
  4. Then
  5. ACXHZD317 route product structure diagram
    ACXHZD317863324-23-6 In Stock
Inquiry

Comments (0)